Humanwell Healthcare (Group) Co.,Ltd.

SSE:600079.SS

21.2 (CNY) • At close June 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994
Revenue 25,435.48424,524.74122,337.71920,548.9320,680.11122,157.42318,910.55115,448.2112,330.9510,053.9787,051.6286,010.2115,317.0933,621.4362,204.7991,330.2091,024.369709.22750.644747.905592.308571.816558.802241.927188.499134.184137.01992.56886.58861.65253.626
Cost of Revenue 14,103.26113,301.52712,615.13811,764.84511,999.65413,487.26111,461.5239,568.0487,794.6936,399.8344,137.5153,514.8563,198.9222,134.5821,179.519624.028534.592385.995453.157443.796340.864357.389341.264127.659102.74974.92275.22358.97960.56341.61336.372
Gross Profit 11,332.22311,223.2149,722.5818,784.0858,680.4578,670.1617,449.0295,880.1624,536.2573,654.1452,914.1132,495.3562,118.1711,486.8551,025.279706.181489.778323.226297.487304.108251.443214.427217.537114.26885.7559.26261.79633.58926.02620.03917.255
Gross Profit Ratio 0.4460.4580.4350.4270.420.3910.3940.3810.3680.3630.4130.4150.3980.4110.4650.5310.4780.4560.3960.4070.4250.3750.3890.4720.4550.4420.4510.3630.3010.3250.322
Reseach & Development Expenses 1,352.8631,461.942966.856810.469767.55595.29486.126796.958321.869276.517204.072157.829125.79974.49252.031000030.23920.0514.7618.4500000000
General & Administrative Expenses -1,385.241593.261414.028-357.769521.468539.455497.87535.317356.009187.327133.103130.951107.22275.81258.246155.37128.16895.22395.00715.47319.34516.91617.00829.2319.45111.9257.8175.7163.7821.7271.052
Selling & Marketing Expenses -1,343.1383,338.9634,274.7084,006.6713,716.614,016.9513,649.2122,606.5851,855.5191,608.5031,264.7821,030.297835.65576.923416.745344.592217.305138.238107.1691.1262.79448.04470.2430.8325.88312.2797.7645.1832.8882.1661.704
SG&A -2,728.3796,240.4114,688.7353,648.9024,238.0784,556.4064,147.0872,641.9022,211.5291,795.831,397.8841,161.248942.872652.736474.99499.961345.473233.462202.167106.59482.13964.9687.24860.0635.33424.20415.58110.8996.673.8932.756
Other Expenses 10,068.01473.6861,156.0121,651.99790.371837.041-36.595-95.434122.10594.49729.86633.61870.18419.90816.4615.914-0.243-3.39-10.0990.726-0.4760.2464.73113.38514.9587.5171.5121.6690.8950.9540.625
Operating Expenses 8,810.1957,776.046,811.6036,111.3615,795.9985,988.7375,451.844,109.1663,141.5072,518.0791,942.6041,605.6411,358.886931.14647.951515.267357.183240.115216.78178.778139.602115.718141.13364.83549.50327.05117.07913.5767.2694.4623.203
Operating Income 2,522.0293,447.1743,516.0283,438.3693,013.1952,881.074-1,463.7643,039.6051,248.629984.161794.861743.445631.127495.195353.298267.203117.729104.951140.7790.93969.20761.19952.03438.69244.47132.56846.30324.89216.18114.77312.907
Operating Income Ratio 0.0990.1410.1570.1670.1460.13-0.0770.1970.1010.0980.1130.1240.1190.1370.160.2010.1150.1480.1880.1220.1170.1070.0930.160.2360.2430.3380.2690.1870.240.241
Total Other Income Expenses Net -99.198-63.345-89.975-76.066-985.865-1,101.636-51.367-82.141115.69187.80826.63226.503-18.24510.32714.659101.161-0.243-3.39-10.361-34.955-51.5540.0252.85612.4856.3786.825-0.0391.30.6210.6380.425
Income Before Tax 2,422.833,383.8293,426.0532,172.9742,027.3311,757.808-1,497.3192,948.2781,365.1871,071.969821.492769.948695.841505.522367.957280.393117.485101.561130.4191.0267.81661.22454.8949.95751.26239.25246.26326.19316.80215.41113.332
Income Before Tax Ratio 0.0950.1380.1530.1060.0980.079-0.0790.1910.1110.1070.1160.1280.1310.140.1670.2110.1150.1430.1740.1220.1140.1070.0980.2060.2720.2930.3380.2830.1940.250.249
Income Tax Expense 644.487568.563354.751354.782385.142442.597493.41628.95285.04218.746185.76168.698132.576.21863.87229.67715.6110.72616.21819.01711.56516.35618.26710.6326.6349.58813.8143.1511.8061.5741.223
Net Income 1,329.7452,134.4852,484.1091,818.1931,642.1891,315.211-2,372.0812,068.593832.403653.824451.771417.78405.991300.354216.466201.47378.19869.441107.47451.43440.21930.68319.26228.91136.37618.9319.80517.8814.25613.1611.765
Net Income Ratio 0.0520.0870.1110.0880.0790.059-0.1250.1340.0680.0650.0640.070.0760.0830.0980.1510.0760.0980.1430.0690.0680.0540.0340.120.1930.1410.1450.1930.1650.2130.219
EPS 0.821.321.541.141.190.97-1.821.530.630.520.390.420.410.310.230.240.10.0850.140.0780.0440.0390.0240.0410.0520.0270.0320.030.020.0190.017
EPS Diluted 0.821.311.541.131.190.97-1.821.530.630.520.390.420.410.310.230.240.10.0850.140.0780.0440.0390.0240.0410.0520.0270.0320.030.020.0190.017
EBITDA 3,799.6474,558.5044,670.6283,454.4593,493.3183,208.645-135.8894,029.5092,134.3711,337.6761,184.1151,065.145922.749669.642453.424353.409217.115188.318212.757171.651130.996119.374101.83277.81869.54136.96748.13320.01318.75715.57714.052
EBITDA Ratio 0.1490.1860.2090.1680.1690.145-0.0070.2610.1730.1330.1680.1770.1740.1850.2060.2660.2120.2660.2830.230.2210.2090.1820.3220.3690.2750.3510.2160.2170.2530.262